TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
851
|
665
|
2,858 |
| Financial expenses |
6
|
3
|
3 |
| Earnings before taxes |
-37
|
-178
|
510 |
| EBITDA |
-30
|
-166
|
522 |
| Total assets |
880
|
1,030
|
1,278 |
| Current assets |
656
|
789
|
1,234 |
| Current liabilities |
68
|
147
|
215 |
| Equity capital |
788
|
854
|
1,004 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
5
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.5%
|
82.9%
|
78.6% |
| Turnover per employee |
170
|
133
|
572 |
| Profit as a percentage of turnover |
-4.3%
|
-26.8%
|
17.8% |
| Return on assets (ROA) |
-3.5%
|
-17.0%
|
40.1% |
| Current ratio |
964.7%
|
536.7%
|
574.0% |
| Return on equity (ROE) |
-4.7%
|
-20.8%
|
50.8% |
| Change turnover |
209
|
-2,202
|
1,585 |
| Change turnover % |
33%
|
-77%
|
124% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.